Current Issue 15 January 2012, Vol. 19, No. 2

Issue Highlights

  • Danshen–Gegen decoction protects against hypoxia/reoxygenation-induced apoptosis by inhibiting mitochondrial permeability transition via the redox-sensitive ERK/Nrf2 and PKCɛ/mKATP pathways in H9c2 cardiomyocytes
    15 January 2012(Vol. 19 | No. 2 | Pages 99-110)

    Po Yee Chiu, Hoi Yan Leung, Pou Kuan Leong, Na Chen, Limin Zhou, Zhong Zuo, Philip Y. Lam, Kam Ming Ko

  • In vitro anti-influenza virus activity of a cardiotonic glycoside from Adenium obesum (Forssk.)
    15 January 2012(Vol. 19 | No. 2 | Pages 111-114)

    Hiroaki Kiyohara, Chikara Ichino, Yuka Kawamura, Takayuki Nagai, Noriko Sato, Haruki Yamada, Maha M. Salama, Essam Abdel-Sattar

  • Kalanchoe pinnata inhibits mast cell activation and prevents allergic airway disease
    15 January 2012(Vol. 19 | No. 2 | Pages 115-121)

    E.A. Cruz, S. Reuter, H. Martin, N. Dehzad, M.F. Muzitano, S.S. Costa, B. Rossi-Bergmann, R. Buhl, M. Stassen, C. Taube

  • Synergism of plant-derived polyphenols in adipogenesis: Perspectives and implications
    27 January 2012

    María Herranz-López, Salvador Fernández-Arroyo, Almudena Pérez-Sanchez, Enrique Barrajón-Catalán, Raúl Beltrán-Debón, Javier Abel Menéndez, Carlos Alonso-Villaverde, Antonio Segura-Carretero, Jorge Joven, Vicente Micol

  • Ginkgo biloba protects against intermittent hypoxia-induced memory deficits and hippocampal DNA damage in rats
    24 January 2012

    Basel A. Abdel-Wahab, Samy M. Abd El-Aziz

  • Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms
    19 January 2012

    Penelope M.Y. Or, Francis F.Y. Lam, Y.W. Kwan, C.H. Cho, C.P. Lau, H. Yu, G. Lin, Clara B.S. Lau, K.P. Fung, P.C. Leung, John H.K. Yeung

  • Antibacterial activity of Thymus maroccanus and Thymus broussonetii essential oils against nosocomial infection – bacteria and their synergistic potential with antibiotics
    18 January 2012

    Mariam Fadli, Asmaa Saad, Sami Sayadi, Jacqueline Chevalier, Nour-Eddine Mezrioui, Jean-Marie Pagès, Lahcen Hassani

  • Suppression of matrix metalloproteinase-9 expression by andrographolide in human monocytic THP-1 cells via inhibition of NF-κB activation
    13 January 2012

    Woan-Ruoh Lee, Chi-Li Chung, Che-Jen Hsiao, Yung-Chen Chou, Po-Jen Hsueh, Po-Chih Yang, Jing-Shiun Jan, Yu-Wen Cheng, George Hsiao

    • View More Articles in Press...

On the Cover

Cover Image

New Issue Alert

Free Trial Issue

;authors

Publishing Information

Phytomedicine is published by Elsevier for ESCOP, European Scientific Cooperative on Phytomedicine.

Elsevier
Access this journal onSciVerse ScienceDirect
Print or Share This Page

Journal Access

Full-text articles are available from 1999 to the present. Access to abstracts is complimentary. Access to full text is limited to ESCOP members as well as personal subscribers.

Activate Online Access

About Phytomedicine

Phytomedicine publishes research results on phytotherapy (clinical trials), phytopharmacology, pharmacognosy, standardization and phytotoxicology, obtained with plant extracts as well as isolated compounds from these extracts and phytopharmaceuticals. This practical reference resource includes information useful not only to researchers in phytopharmacology, phytotherapy and phytotoxicology, but to drug regulatory authorities as well. Phytomedicine consists of:

  • case reports
  • pharmacological and molecularbiological studies
  • screening studies (only when focused on plant extracts or isolated compounds with extraordinary activities)
  • chemical structure — activity studies
  • chemical analysis and standardization of plant drugs and phytopharmaceuticals
  • invited reviews

About the European Scientific Cooperative on Phytomedicine

ESCOP, European Scientific Cooperative on Phytomedicine is an umbrella organisation representing national phytotherapy associations across Europe, especially in their discussions with European medicine regulators. Since 1996 it has been a company limited by guarantee in the United Kingdom. ESCOP aims to advance the scientific status of phytomedicines and to assist with the harmonisation of their regulatory status at the European level.